A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer

Hope S. Rugo, A. Jo Chien, Sandra X. Franco, Alison T. Stopeck, Alexa Glencer, Soumi Lahiri, Michael C. Arbushites, Janet Scott, John W. Park, Clifford Hudis, Ben Nulsen, Maura N. Dickler

Research output: Contribution to journalReview articlepeer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences